on EUROPLASMA (EPA:ALEUP)
EUROPLASMA: Results for the First Half of 2025
Europlasma announces a significant increase in its revenue for the first half of 2025, reaching €32.9 million, an increase of 111% compared to 2024. This increase is mainly due to the dynamism of the Industries segment, particularly following the integration of FDB Industries. However, the group suffered from unfavorable consolidated EBITDA, mainly caused by operational challenges in asbestos waste treatment and at Valdunes Industries. Financial results were heavily impacted by debt-related costs. Furthermore, the defense and rail sectors showed positive commercial momentum. Europlasma continues to invest to support this growth in its various business lines.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all EUROPLASMA news